Evaluation of hepatitis B surface antibody and specific gamma interferon response in health care workers after vaccination

Jundishapur Journal of Microbiology

Volumn 8, Issue 1, 2015, Pages

  Shooshtari, Mohammad Hosein Sarmast ^a   Makvandi, Manoochehr ^a   Rasti, Mojtaba ^a   Neisi, Niloofar ^a   Rastegarvand, Nasrin ^a   Pouremamali, Amir ^a   Haj, Mehrdad Sadeghi ^a   Ghaedi, Fardin ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hepatitis B virus; Interferon gamma; Workers

Indexed keywords

GAMMA INTERFERON; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE;

ADULT; ANESTHESIST; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENERAL PRACTITIONER; HEALTH CARE PERSONNEL; HEPATITIS B; HIGH RISK POPULATION; HUMAN; HUMAN CELL; INTERFERON GAMMA RELEASE ASSAY; IRAN; MALE; NEUROSURGEON; NURSE; OCCUPATIONAL EXPOSURE; ORTHOPEDIC SPECIALIST; PERIPHERAL BLOOD MONONUCLEAR CELL; SEROLOGY; SURGEON; UROLOGIST; VACCINATION;

HEPATITIS B VIRUS;

EID: 84918840786     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/jjm.13801     Document Type: Article

References (23)

1. Mizukoshi E, Sidney J, Livingston B, Ghany M, Hoofnagle JH, Sette A, et al. Cellular immune responses to the hepatitis B virus polymerase. J Immunol. 2004;173(9):5863-71.
2. Alavian SM, Mahboobi N, Mahboobi N. Anti-HBs antibody status and some of its associated factors in dental health care workers in Tehran University of Medical Sciences: Anti-HBs Ab and associated factors in dental society. Hepat Mon. 2011;11(2):99-102.
3. Di Giuseppe G, Nobile CG, Marinelli P, Angelillo IF. A survey of knowledge, attitudes, and behavior of Italian dentists toward immunization. Vaccine. 2007;25(9):1669-75.
4. Mahoney FJ, Stewart K, Hu H, Coleman P, Alter MJ. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med. 1997;157(22):2601-5.
5. Wang J, Gujar SA, Cova L, Michalak TI. Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity. J Virol. 2007;81(2):903-16.
6. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 1996;4(1):25-36.
7. Mancini-Bourgine M, Fontaine H, Brechot C, Pol S, Michel ML. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. Vaccine. 2006;24(21):4482-9.
8. Mast E, Mahoney F, Kane M, Margolis H. Hepatitis B vaccine. In: Plotkin SA, Orenstein W. A. editors. Vaccines. Philadelphia: WBSaunders; 2004. p. 299 -337.
9. Poland GA, Jacobson RM. Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med. 2004;351(27):2832- 8.
10. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep. 1991;40(RR- 13):1-25.
11. Poland GA. Hepatitis B immunization in health care workers. Dealing with vaccine nonresponse. Am J Prev Med. 1998;15(1):73-7.
12. Sjogren MH. Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination. Am J Med. 2005;118 Suppl 10A:34S-9S.
13. Hamidi B, Bahadori M, Mansouri S, Nategh R. Seroepidemiological survey of hepatitis B markers in National Iranian Oil Company (NIOC) health workers in Tehran prior to mass vaccination. Arch Irn Med. 2000;3:1-5.
14. Jafarzadeh A, Montazerifar SJ. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth. J Ayub Med Coll Abbottabad. 2006;18(4):4-9.
15. Jafarzadeh A, Zarei S, Shokri F. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates. Vaccine. 2008;26(2):269-76.
16. Alavian SM, Mansouri S, Abouzari M, Assari S, Bonab MS, Miri SM. Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005). Eur J Gastroenterol Hepatol. 2008;20(2):131-4.
17. Bahmani MK, Khosravi A, Mobasser A, Ghezelsofla E. Seroprevalence of hepatitis B virus infection and vaccination compliance among health care workers in Fars Province, Iran. Arch Clin Infect Dis. 2010;5(1):45-50.
18. Lu CY, Ni YH, Chiang BL, Chen PJ, Chang MH, Chang LY, et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis. 2008;197(10):1419-26.
19. Saberifiroozi M, Gholamzadeh S, Serati AR. The long-term immunity among health care workers vaccinated against hepatitis B virus in a large referral hospital in southern Iran. Arch Iran Med. 2006;9(3):204-7.
20. Bertoletti A, Tan AT, Gehring AJ. HBV-Specific Adaptive Immunity. Viruses. 2009;1(2):91-103.
21. Dimitropoulou D, Karakantza M, Theodorou GL, Leonidou L, Assimakopoulos SF, Mouzaki A, et al. Serum cytokine profile in patients with hepatitis B e antigen-negative chronic active hepatitis B and inactive hepatitis B virus carriers. World J Gastrointest Pathophysiol. 2013;4(1):24-7.
22. Kardar GA, Jeddi-Tehrani M, Shokri F. Diminished Th1 and Th2 cytokine production in healthy adult nonresponders to recombinant hepatitis B vaccine. Scand J Immunol. 2002;55(3):311-4.
23. Jafarzadeh A, Shokri F. TH1 and TH2 responses are influenced by HLA antigens in healthy neonates vaccinated with recombinant hepatitis B vaccine. Iran J Allergy Asthma Immunol. 2012;11(4):308-15.